XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Collaboration revenue $ 302 $ 468 $ 1,090 $ 1,932
Operating expenses:        
Research and development 41,881 17,260 96,125 68,378
General and administrative 15,256 8,724 41,174 32,121
Total operating expenses 57,137 25,984 137,299 100,499
Loss from operations (56,835) (25,516) (136,209) (98,567)
Other income:        
Other income, net 4,925 884 12,069 2,168
Total other income 4,925 884 12,069 2,168
Net loss $ (51,910) $ (24,632) $ (124,140) $ (96,399)
Net loss per share attributable to common stockholders, basic (in dollars per share) [1] $ (2.75) $ (2.72) $ (7.21) $ (16.73)
Net loss per share attributable to common stockholders, diluted (in dollars per share) [1] $ (2.75) $ (2.72) $ (7.21) $ (16.73)
Weighted average common shares outstanding, basic (in shares) [1] 18,884,562 9,039,427 17,210,604 5,763,121
Weighted average common shares outstanding, diluted (in shares) [1] 18,884,562 9,039,427 17,210,604 5,763,121
[1] Results have been retroactively adjusted to reflect the 1-for-15 reverse stock split effected on November 28, 2023. See Note 2 for details.